Skip to main content
. 2016 Aug 31;36(4):e00374. doi: 10.1042/BSR20160199

Figure 2. NBL1 inhibits expression and activation of cyclin D1–CDK4 and phosphorylation of p27 in human PASMCs.

Figure 2

(A) Western blotting and densitometric analysis. (B) Human PASMCs were pretreated by NBL1 (0.5 μM) for 1 h and then stimulated with PDGF-BB for 24 h. GAPDH was used as the loading protein. (C) Cross co-immuoprecipitation (IP) and western blots (WB). Human PASMCs were stimulated with PDGF-BB for 3 h following NBL1 pretreatment. *P<0.05, **P<0.01, compared with control, ##P<0.01, compared with PDGF-BB treatment.